Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?

dc.contributor.author	Abdelhak, Ahmed
dc.date.accessioned	2020-05-20T08:17:39Z
dc.date.available	2020-05-20T08:17:39Z
dc.date.issued	2019
dc.identifier.issn	1664-2295
dc.identifier.uri	http://hdl.handle.net/10900/100814
dc.language.iso	en	en
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fneur.2019.00280
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_02080
utue.personen.roh	Abdelhak, Ahmed
utue.personen.roh	Hottenrott, Tilman
utue.personen.roh	Morenas-Rodriguez, Estrella
utue.personen.roh	Suarez-Calvet, Marc
utue.personen.roh	Zettl, Uwe K.
utue.personen.roh	Haass, Christian
utue.personen.roh	Meuth, Sven G.
utue.personen.roh	Rauer, Sebastian
utue.personen.roh	Otto, Markus
utue.personen.roh	Tumani, Hayrettin
utue.personen.roh	Huss, Andre
dcterms.isPartOf.ZSTitelID	Frontiers in Neurology	de_DE
dcterms.isPartOf.ZS-Issue	Article 280	de_DE
dcterms.isPartOf.ZS-Volume	10	de_DE
utue.fakultaet	04 Medizinische Fakultät

Files in this item

Files	Size	Format	View
There are no files associated with this item.